Incretin mimetic can refer to any drug that mimics the actions of one or more incretin hormones. They are used for type 2 diabetes.[1][2]

Specific incretin mimetics include:

References

  1. ↑ Research, Center for Drug Evaluation and (2 March 2022). "Incretin mimetic drugs for type 2 diabetes". FDA. Retrieved 5 November 2023.
  2. ↑ "Incretin Based Treatments". Diabetes Education Online. Retrieved 5 November 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.